Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer

NCT05673811 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Adenocarcinoma
Metastatic

Interventions

DRUG: Nab-paclitaxel
DRUG: Gemcitabine
GENETIC: VCN-01

Sponsor

Theriva Biologics SL